🗞️ Daily Business Brief – NOV 03,2025
- OYO rolls back controversial bonus share plan after investor pushback; to issue new structure soon. Earlier plan proposed one bonus share for every 6,000 held under PRISM, linked to IPO; faced backlash from smaller shareholders.
- Zydus Lifesciences to weigh ₹5,000 crore fundraise ahead of Q2 results announcement.
- RITES secures ₹372.68 crore order from NIMHANS for PMC of new OPD building.
- Indian industry seeks 15% duty on aluminium imports and stricter quality norms to curb dumping.
- Groww IPO Update: Anchor book receives bids worth over ₹50,000 crore; anchor size ₹2,950 crore. Major bidders include Norges, ADIA, GIC, Sequoia, Coatue, and Dragoneer.
- Zepto removes handling and surge fees from all orders after $450 million funding boost.
- Vodafone Idea gets big relief as Supreme Court clarifies govt free to consider relief on both additional and reassessment of all AGR dues; Indus Towers rebounds 10% from lows.
- India’s Trade Ministry confirms European Union negotiators in New Delhi to discuss trade deals.
- Narayana Hrudayalaya expands globally with acquisition of UK-based Practice Plus Group Hospitals for £183 million. Marks entry into UK healthcare market; plans to leverage NHS contracts and digital Athma platform for scalable growth.
- Arvind SmartSpaces targets large-scale growth via ₹700-crore Baroda township launch and ₹3,124-crore unrecognized revenue. Focuses on Gujarat–Bengaluru–MMR pipeline and strong cash flow generation for scalability.
- VRL Logistics eyes operational revival through exit from low-margin segments, new branch additions, and strict cost control. Aims for sustainable EBITDA margin expansion via tonnage recovery and higher realization per ton.
- Titan Company targets continued double-digit growth by deepening jewelry leadership, scaling watches, eyewear, and lifestyle brands. Expanding into GCC through Damas Jewellery acquisition to strengthen global luxury ecosystem.
- Stallion India Fluorochemicals promoter sells part of shareholding to fund R-32 manufacturing facility at Bhilwara.
- Cipla to acquire 100% stake in Inzpera Healthsciences Ltd for ₹110.65 crore; Inzpera specializes in pediatric pharma and wellness products.
- Tata Consumer Products – Foods business growth at 19% vs estimated 12–14%; international business revenue grew 9% vs estimated 6–7% for the quarter.
🔔 Stay tuned for daily insights into India Inc, markets & macro stories!
